Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

294 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Completed

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

NCT03206203

Conditions
Breast Diseases, Breast Neoplasms, HER2 Negative, +8 more
Locations
  • Georgetown University Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Indiana University Health Melvin Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease

NCT03487666

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers

NCT03251378

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • California Cancer Care Associates for Research & Excellence, Inc. San Marcos, California, United States
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View Trial Details
Completed

Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer

NCT04464174

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Champalimaud Clinical Centre - Champalimaud Foundation Lisbon, Portugal
  • Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto) Porto, Portugal
  • Hospital Provincial de Castellón Castellon, Castellón, Spain
  • Hospital Clínico Universitario Virgen de la Arrixaca El Palmar, Murcia, Spain
View all 14 locations
View Trial Details

Related conditions